Closure of defects of the atrial septum in adults using the amplatzer device: 100 Consecutive patients in a single center

Clinical Cardiology

Volumn 27, Issue 9, 2004, Pages 509-513

  Purcell, I F ^a   Brecker, Stephen J ^b   Ward, D E ^b  

^a FREEMAN HOSPITAL   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Adult; Amplatzer; Atrial septal defect; Patent foramen ovale; Transcatheter

Indexed keywords

ADULT; AGED; ARTICLE; DOSIMETRY; FEMALE; FLUOROSCOPY; HEART ATRIUM SEPTUM; HEART ATRIUM SEPTUM DEFECT; HEART FORAMEN OVALE; HEART TAMPONADE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; RADIATION EXPOSURE; RADIATION HAZARD; SAFETY; WOUND CLOSURE;

EID: 4344716903     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960270907     Document Type: Article

References (28)

1. Campbell M: Natural history of atrial septal defect. Br Heart J 1970;32 (6):820-826
2. Murphy JG, Gersh BJ, McGoon MD, Mair DD, Porter CJ, Ilstrup DM, McGoon DC, Puga FJ, Kirklin JW, Danielson GK: Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med 1990;323(24):1645-1650
3. Konstantinides S, Geibel A, Olschewski M, Gomandt L, Roskamm H, Spillner G, Just H, Kasper W: A comparison of surgical and medical therapy for atrial septal defect in adults. N Engl J Med 1995;333(8):469-473
4. Moon RE, Camporesi EM, Kisslo JA: Patent foramen ovale and decompression sickness in divers. Lancet 1989;1(8637):513-514
5. Cabanes L, Mas JL, Cohen A, Amarenco P, Cabanes PA, Oubary P, Chedru F, Guerin F, Bousser MG, de Recondo J: Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993;24(12):1865- 1873
6. Van Camp G, Schulze D, Cosyns B, Vandenbossche JL: Relation between patent foramen ovale and unexplained stroke. Am J Cardiol 1993;71(7): 596-598
7. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J: Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345(24):1740-1746
8. Berger F, Vogel M, Alexi-Meskishvili V, Lange PE: Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects. J Thorac Cardiovasc Surg 1999;118(4):674-678; discussion 678-680
9. Cowley CG, Lloyd TR, Bove EL, Gaffney D, Dietrich M, Rocchini AP: Comparison of results of closure of secundum atrial septal defect by surgery versus Amplatzer septal occluder. Am J Cardiol 2001;88(5):589-591
10. Thomson JD, Aburawi EH, Watterson KG, Van Doom C, Gibbs JL: Surgical and transcatheter (Amplatzer) closure of atrial septal defects: A prospective comparison of results and cost. Heart 2002;87(5):466-469
11. Nendaz MR, Sarasin FP, Junod AF, Bogousslavsky J: Preventing stroke recurrence in patients with patent foramen ovale: Antithrombotic therapy, foramen closure, or therapeutic abstention? A decision analytic perspective. Am Heart J 1998;135(3):532-541
12. Windecker S, Wahl A, Chatterjee T, Garachemani A, Eberli FR, Seiler C, Meier B: Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: Long-term risk of recurrent thromboembolic events. Circulation 2000;101(8):893-898
13. Losay J, Petit J, Lambert V, Esna G, Berthaux X, Brenot P, Angel C: Percutaneous closure with Amplatzer device is a safe and efficient alternative to surgery in adults with large atrial septal defects. Am Heart J 2001;142(3):544-548
14. Hung J, Landzberg MJ, Jenkins KJ, King ME, Lock JE, Palacios IF, Lang P: Closure of patent foramen ovale for paradoxical emboli: Intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol 2000;35(5):1311-1316
15. Demkow M, Ruzyllo W, Konka M, Kepka C, Kowalski M, Wilczynski J, Rydlewska-Sadowska W: Transvenous closure of moderate and large secundum atrial septal defects in adults using the Amplatzer septal occluder. Cathet Cardiovasc Interv 2001;52(2):188-193
16. Dhillon R, Thanopoulos B, Tsaousis G, Triposkiadis F, Kyriakidis M, Redington A: Transcatheter closure of atrial septal defects in adults with the Amplatzer septal occluder. Heart 1999;82(5):559-562
17. Chessa M, Carminati M, Butera G, Bini RM, Drago M, Rosti L, Giamberti A, Pome G, Bossone E, Frigiola A: Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 2002;39(6):1061-1065
18. Berger F, Ewert P, Bjornstad PG, Dahnert I, Krings G, Brilla-Austenat I, Vogel M, Lange PE: Transcatheter closure as standard treatment for most interatrial defects: Experience in 200 patients treated with the Amplatzer septal occluder. Cardiol Young 1999;9(5):468-473
19. Chan KC, Godman MJ, Walsh K, Wilson N, Redington A, Gibbs JL: Transcatheter closure of atrial septal defect and interatrial communications with a new self expanding nitinol double disc device (Amplatzer septal occluder): Multicentre UK experience. Heart 1999;82(3):300-306
20. Ewert P, Berger F, Daehnert I, van Wees J, Gittermann M, Abdul-Khaliq H, Lange PE: Transcatheter closure of atrial septal defects without fluoroscopy: Feasibility of a new method. Circulation 2000;101(8):847-849
21. Ende DJ, Chopra PS, Rao PS: Transcatheter closure of atrial septal defect or patent foramen ovale with the buttoned device for prevention of recurrence of paradoxic embolism. Am J Cardiol 1996;78(2):233-236
22. Du ZD, Cao QL, Joseph A, Koenig P, Heischmidt M, Waight DJ, Rhodes J, Brorson J, Hijazi ZM: Transcatheter closure of patent foramen ovale in patients with paradoxical embolism: Intermediate-term risk of recurrent neurological events. Cathet Cardiovasc Interv 2002;55(2):189-194
23. Masura J, Gavora P, Formanek A, Hijazi ZM: Transcatheter closure of secundum atrial septal defects using the new self-centering Amplatzer septal occluder: Initial human experience. Cathet Cardiovasc Diagn 1997;42(4): 388-393
24. Walsh KP, Wilmshurst PT, Morrison WL: Transcatheter closure of patent foramen ovale using the Amplatzer septal occluder to prevent recurrence of neurological decompression illness in divers. Heart 1999;81(3):257-261
25. Taeed R, Shim D, Kimball TR, Michelfelder EC, Salaymeh KJ, Koons LM, Beekman RH III: One-year follow-up of the Amplatzer device to close atrial septal defects. Am J Cardiol 2001;87(1):116-118, A9
26. Hijazi ZM, Cao Q, Patel HT, Rhodes J, Hanlon KM: Transesophageal echocardiographic results of catheter closure of atrial septal defect in children and adults using the Amplatzer device. Am J Cardiol 2000;85(11): 1387-1390
27. Sharafuddin MJ, Gu X, Titus JL, Urness M, Cervera-Ceballos JJ, Amplatz K: Transvenous closure of secundum atrial septal defects: Preliminary results with a new self-expanding nitinol prosthesis in a swine model. Circulation 1997;95(8):2162-2168
28. Fischer G, Kramer HH, Stieh J, Harding P, Jung O: Transcatheter closure of secundum atrial septal defects with the new self-centering Amplatzer septal occluder. Eur Heart J 1999;20(7):541-549